International Journal of Medicine and Medical Sciences
Subscribe to IJMMS
Full Name*
Email Address*

Article Number - 545FCDC10

Vol.5(9), pp. 380-390 , September 2013
DOI: 10.5897/IJMMS2013.0902
ISSN: 2006-9723

Applications of recombinant protein therapeutic agents in periodontics contributors

Neha Sethi
  • Neha Sethi
  • Department of Periodontics College, IDEAS Dental College, Address, Gwalior, India.
  • Google Scholar

 Accepted: 29 March 2013  Published: 01 September 2013

Copyright © 2013 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0

Based on the improved understanding of cell and molecular biology of periodontal wound healing, the recombinant technology comprising rh growth factors and carrier construct is applied in periodontal regeneration. In 1997, the first recombinant (that is, synthetic) protein therapeutic agent was approved by the US Food and Drug Administration (FDA). In this paper we review the two commercially available recombinant agents, that is, rhPDGF-BB and rh-BMP-2 used for periodontal regeneration.

Key words: Periodontal regeneration, recombinant proteins, gene, tissue regeneration.


Allori AC, Sailon AM, Pan JH, Warren SM (2008). Biological basis of bone formation, remodeling, and repair-part III: biomechanical forces. Tissue Eng. Part B. Rev. 14(3):285-293.
Barboza EP, Duarte MEL, Geolas L, Sorensen RG, Riedel GE, Wikesjo UME (2000). Effect of recombinant human bone morphogenetic protein 2 in an absorbable collagen sponge with space providing biomaterials on the augmentation of chronic alveolar ridge defects. J Periodontol 75:702-708.
Barboza EP, Caúla AL, Caúla Fde O, de Souza RO, Geolás Neto L, Sorensen RG, Li XJ, Wikesjö UM (2004). Effect of recombinant human bone morphogenetic protein-2 in an absorbable collagen sponge with space-providing biomaterials on the augmentation of chronic alveolar ridge defects. J. Periodontol. 75(5):702-708.
Bartold PM, Raben A (1992). Growth factor modulation of fibroblasts in stimulated wound healing. J. Periodont Res. 31:205-216.
Bessho K, Kusumoto K, Fujimura K, Konishi Y, Ogawa Y, Tani Y, Iizuka T (1999) Comparison of recombinant and purified human bone morphogenetic protein. Br. J. Oral Maxillofac Surg. 37(1):2–5.
Blom S, Holmstrup P, Dabelsteen E (1994). A comparison of the effect of EGF, PDGF and FGF on rat periodontal ligament fibroblast like cells DNA synthesis and morphology. J. Periodontol. 65:373.
Boden SD (2001). Clinical applications of the BMPs. J Bone Joint Surg Am 83 A (Suppl 1) S161
Bouletreau PJ, Warren SM, Spector JA, Steinbrech DS, Mehrara BJ, Longaker MT (2002). factors in fracture microenvironment induce primary osteoblast angiogenic cytokine production. Plast Reconstr Surg. 110:139-148.
Bowen-Pope DF, Malpass TW, Foster DM Ross R (1988). platelet derived growth factor in vivo: Levels, activity, and rate of clearance. blood 64:458-469.
Boyan LA, Bhargava G, Nishimura F, Orman R, Price R, Terranova VP (1994). Mitogenic and chemotactic responses of human periodontal ligament cells to the different isoforms of platelet derived growth factor. J. Dent. Res. 73:1593.
Boyne PJ, Lilly LC, Marx RE, Moy PK, Nevins M, Spagnoli DB, Triplett RG (2005). De novo bone induction by recombinant human bone morphogenetic protein-2 (rhBMP-2) in maxillary sinus floor augmentation. J. Oral Maxillofac Surg. 63(12):1693-16707.
Boyne PJ, Marx RE (1997). A feasibility study evaluating rhBMP-2/absorbable collagen sponge for maxillary sinus floor augmentation. Int J Periodontics Restorative Dent. 17(1):11-25.
Canalis E, McCarthy TL, Centrella M (1989). Effects of PDGF on bone formation in vitro. J. Cell Physiol. 140:530-537.
Cho TJ, Gerstenfeld LC, Einhorn TA (2002). Differential temporal expression of members of the transforming growth factor beta superfamily durring murine fracture healing. J Bone Miner Res. 17:513-520.
Franchimont N, Rydziel S, Canalis E (1997). Interleukin 6 is autoregulated by transcriptional mechanisms in cultures of rat osteoblastic cells. J Clin Invest. 100(7):1797-803.
PMid:9312180 PMCid:PMC508365
Glenn Walker, Ariel Hanson;; Ruwan Sumansinghe; Michelle Wall; Elizabeth Loboa (2005) Seeding of human mesenchymal stem cells onto poly-l-lactic acid (PLLA) scaffolds in a flow perfusion microfluidic chamber. Proceedings of the 2005 Summer Bioengineering Conference. 2005:1596-1597.
Giannobile WV, Hernandez RA, Finkelman RD, Ryan S, Kiritsy CP, D'Andrea M, Lynch SE (1996). Comparative effects of platelet derived growth factor–BB and insulin like growth factor–1, individually and in combination, on periodontal regeneration in Macaca fascicularis. J. Periodont Res. 31:301-312.
Hadjiargyrou M, Lombardo F, Zhao S, Ahrens W, Joo J, Ahn H, Jurman M, White DW, Rubin CT (2002). Transcriptional profiling of bone regeneration :insight into the molecular complexity of wound repair. J Biol. Chem. 277:30177-30182.
Hanisch O, Sorensen RG, Kinoshita A, Spiekermann H, Wozney JM, Wikesjö UM (2003). Effect of recombinant human bone morphogenetic protein-2 in dehiscence defects with non-submerged immediate implants: an experimental study in Cynomolgus monkeys. J. Periodontol. 74(5):648-657.
Hirota S, Imakita M, Kohri K, Ito A, Morii E, Adachi S, Kim HM, Kitamura Y, Yutani C, Nomura S (1993). Expression of osteopontin messenger RNA by macrophages in atherosclerotic plaques. A possible association with calcification. Am. J. Pathol. 143:1003–1008.
PMid:8213995 PMCid:PMC1887054
Hollinger JO, Hart CE, Hirsch SN, Lynch S, Friedlaender GE (2008). Recombinant human platelet-derived growth factor: Biology and clinical applications. J. Bone Joint Surg. Am. 90 Suppl 1:48-54.
Hughes FJ, Aubin JE (1992). Differential chemotactic responses of different populations of fetal rat calvarial cells to PDGF and TGF beta. Bone mineral 19:63.
Huang JS, Huang SS, Deuel TF (1983). human platelet derived growth factor; Radioimmunoassay and discovery of a specific plasma-binding protein. J. Cell Biol. 97:383-388.
KIMURA M, Akira S, Emiko S, Yoshinori K, Toshinori N, Fumihiko Y, Tsuyoshi K, Yoshiyuki H, Tomomi T, Noboru O (2013). Periodontal regeneration following application of basic fibroblast growth factor-2 in combination with beta tricalcium phosphate in class III furcation defects in dogs Dental Materials J. 32(2):256-262.
kugimiya F, Kawaguchi H, Kamekura S, Chikuda H, Ohba S, Yano F, Ogata N, Katagiri T, Harada Y, Azuma Y, Nakamura K, Chung UI (2005). Involvement of endogenous bone morphogenic protein (BMP-2) and BMP 6 in bone formation. J. Biol. Chem. 280:35704-35712.
Jonk C, Luigi J, Itoh S, Heldin C-H, Dijke P, Kruijer W (1998). Identi®cation and functional characterization of a Small binding element (SBE) in the JunB promoter that acts as a transforming growth factor-, activin, and bone morphogenetic protein-inducible enhancer. J Biol Chem 273:21145 - 21152.
Jovanovic SA, Hunt DR, Bernard GW, Spiekermann H, Nishimura R, Wozney JM, Wikesjö UME (2003). Long-term functional loading of dental implants in rhBMP-2 induced bone. A histologic study in the canine ridge augmentation model. Clin. Oral Implants Res. 14:793-803.
Lim WH, Thomson RC, Cook AD, Wozney JM (2003). periodontal repair in dogs: Evaluation of a bioabsorbable space -providing macroporous membrane with recombinant human bone morphogenetic protein -2. J. Periodontol. 74:635-647.
Lecanda F, Avioli LV, Cheng SL (1997). Regulation of bone matrix protein expression and induction of differentiation of human osteoblasts and human bone marrow stromal cells by bone morphogenetic protein-2. J. Cell Biochem. 67(3):386-396.<386::AID-JCB10>3.0.CO;2-B
Li G, Cui Y, McIlmurray L, Allen WE, Wang H (2005). rhBMP-2, rhVEGF(165), rhPTN and thrombin-related peptide, TP508 induce chemotaxis of human osteoblasts and microvascular endothelial cells. J Orthop Res. 23(3):680-685. Epub 2005 Apr 7.
Lynch SE, de Castilia, GR Williams, RC Kiritsy, CP Howell, TH Reddy, MS (1991). The effects of short term application of a comination of platelet derived and insulin like growth factor on periodontal wound healing. J. Periodontol. 62:458-467.
Lynch SE (2008). Tissue engineering: Applications in maxillofacial surgery and periodondics. Chicago Quintessence.
Murakami S, Noda M (2000). expression of indian heghehog during fracture healing. calcif Tissue Int 2006. 66:272- 276.
McGuire MK, Kao RT, Nevins M, Lynch SE. rhPDGF-BB promotes healing of periodontal defects: 24-month clinical and radiographic observations. Int. J. Periodontics Restorative Dent. 2006, 26:223–
390 Int. J. Med. Med. Sci. 231.
Nakamura, CM, Takako H, Shigeyuki W, Toshiomi Y (2003). In vitro Proliferation of Human Bone Marrow Mesenchymal Stem Cells Employing Donor Serum and Basic Fibroblast Growth Factor, Cytotechnology. 43(1-3):89–96. doi: 10.1023/B:CYTO.0000039911.46200.61
Nevins M, Giannobile WV (2003). Platelet-derived growth factor stimulates bone fill and rate of attachment level gain: results of a large multicenter randomized controlled trial. J Periodontol. 76(12):2205-2215.
Nevins M, Giannobile WV, McGuire MK, Kao RT, Mellonig JT, Hinrichs JE, McAllister BS, Murphy KS, McClain PK, Nevins ML, Paquette DW, Han TJ, Reddy MS, Lavin PT, Genco RJ, Lynch SE (2005). Platelet-derived growth factor stimulates bone fill and rate of attachment level gain: Results of a large multicenter randomized controlled trial. J. Periodontol. 76:2205–2215.
Nevins M, Hanratty J, Lynch SE (2007). Clinical results using recombinant human platelet derived growth factor and mineralized freeze-dried bone allograft in periodontal defects. Int. J. Periodontics Restorative Dent. 27:421–427.
Oates TW, Rouse CA, Cochran DL (1993). Mitogenic effects of growth factors on human periodontal ligament cells in vitro. J. Periodontol. 64:142-148.
Pietrzak WS, Eppley B (2005). Platelet rich plasma: Biology and new technology. J. Craniofac. Surg. 16:1043-1054.
Piches JE, Carnes Dl, Graves DT (1992). Initial characterization of cells derived from human periodontium. J Periodont Res. 68:761-767.
Rajshankar O, McCulloch CAO, Tenenbaum HC, Lekic PC (1998). Osteogenic inhibition by rat periodontal ligament cells: modulation of bone morphogenic protein-7 adivity in vivo. Cell Tiss. Res. 294:475483.
Rutherford RB, Ryan ME, Kennedy JE, Tucker MM, Charette MF (1993). Platelet–derived growth factor and dexamethasone combined with a collagen matrix induces regeneration of the periodontium in monkeys. J. Clin. Periodontal. 20:537-544.
Risau W (1997). Mechanisms of angiogenesis. Nature 17;386(6626):671-6714.
Ripamonti U, Heliotis M, Van Den Heever B, Reddi AH (1994). Bone morphogenetic proteins induce periodontal regeneration in the baboon (Papio ursinus). J. Periodont Res. 29:439-445.
Rosen V, Thies RS (1992). The BMP proteins in bone formation and repair. Trends Genet. 8:97-102.
Rydziel S, Durant D, Canalis E (2000). Platelet-derived growth factor induces collagenase 3 transcription in osteoblasts through the activator protein 1 complex. J. Cell Physiol. 184(3):326-333.<326::AID-JCP6>3.0.CO;2-S
Sutherland D, Bostrom M (2007). Grafts and bone graft substitutes. Lieberman JR page xvi.
Sigurdsson TJ, Lee MB, Kubota K (1993). Periodontal regenerative potential of space–providing expanded polytetrafluoroethylene membranes and recombinant human bone morphogenetic proteins. J. Periodontol. 65:511-521.
Schwartz MA, Ren XD (2000). Determination of GTP loading on Rho. Methods Enzymol. 325:264–272.
van den Bergh JP, ten Bruggenkate CM, Groeneveld HH, Burger EH, Tuinzing DB (2000) Recombinant human bone morphogenetic protein-7 in maxillary sinus floor elevation surgery in 3 patients compared to autogenous bone grafts. A clinical pilot study. J. Clin. Periodontol. 27(9):627-636.
Wang HL, Pappert TD, Castelli WA, Chiego DJ Jr, Shyr Y, Smith BA (1994). The effect of platelet derived growth factor on the cellular response of the periodontium: An autoradiographic study. J. Periodontol.65:429.
Wozney J, Rosen V, Celeste AJ, Mitsock LM, Whitters MJ, Kriz RW, Hewick RM, Wang EA (1988). Novel regulators of bone formation: Molecular clones and activities. Science 242:1528-1534.
Wikesjö UM, Xiropaidis AV, Thomson RC, Cook AD, Selvig KA, Hardwick WR (2003). Periodontal repair in dogs: space-providing ePTFE devices increase rhBMP-2/ACS-induced bone formation. J. Clin. Periodontol. 30(8):715-25.
Wieman TJ, Smiell JM, Su Y (1998). Efficacy and safety of a topical gel formulation of recombinant human platelet-derived growth factor-BB (becaplermin) in patients with chronic neuropathic diabetic ulcers. A phase III randomized placebo-controlled double-blind study. Diabetes Care. May;21(5):822-827.
Yasko A W, Lane J M, Fellinger E J, Rosen V, Wozney J M, Wang EA (1992). The healing ofsegmental bone defects, induced by recombinant human bone morphogenetic protein (rhBMP-2), a radiographic, histological, and biomechanical study in rats. J. Bone Joint Surg. Am. 74:659-670
Zaman KU, Sugaya T, Kato H (1990). Effect of recombinant human platelet derived growth factor BB and bone morphogenetic protein 2 application to demineralized dentin on early periodontal ligament cell response. J. Periodontal Res. 34:244-250
Zhao M, Qiao M, Oyajobi BO, Mundy GR, Chen D (2003) E3 ubiquitin ligase Smurf1 mediates core-binding factor alpha1/Runx2 degradation and plays a specific role in osteoblast differentiation. J Biol Chem. 278(30):27939-27944.



APA (2013). Applications of recombinant protein therapeutic agents in periodontics contributors. International Journal of Medicine and Medical Sciences, 5(9), 380-390.
Chicago Neha Sethi. "Applications of recombinant protein therapeutic agents in periodontics contributors." International Journal of Medicine and Medical Sciences 5, no. 9 (2013): 380-390.
MLA Neha Sethi. "Applications of recombinant protein therapeutic agents in periodontics contributors." International Journal of Medicine and Medical Sciences 5.9 (2013): 380-390.
DOI 10.5897/IJMMS2013.0902

Subscription Form